Overview


According to FutureWise analysis the market for interventional radiology in 2023 is US$ 27.12 billion, and is expected to reach US$ 40.75 billion by 2031 at a CAGR of 5.22%.

Interventional Radiology is a medical speciality that diagnoses and treats a wide variety of medical disorders using minimally invasive procedures. Interventional radiologists use a range of imaging techniques, such as X-rays, CT scans, MRI scans, and ultrasounds, to guide small instruments such as catheters and wires through the body to diagnose and treat diseases or conditions. The field of interventional radiology has seen tremendous growth over the last few decades, thanks to advancements in imaging technology and new techniques and devices that have made many procedures safer and more effective. By using image-guided techniques, interventional radiologists are able to diagnose and treat many different medical conditions with less trauma to the patient, less pain, and shorter recovery times. IR procedures are less invasive than traditional surgical procedures and often do not require general anesthesia. Instead, local anesthesia is typically used, allowing the patient to be awake and alert during the procedure. This reduces the risks associated with general anesthesia, such as respiratory complications, and allows for a faster recovery time.

Some of the common interventional radiology procedures include angiography, angioplasty and stenting, embolization, biopsy, and drainage. These procedures can be used to treat a range of conditions, including cancer, cardiovascular disease, uterine fibroids, and varicose veins. Interventional radiology has revolutionized the way many medical conditions are diagnosed and treated, providing minimally invasive alternatives to traditional surgical procedures. The use of image-guided techniques has led to improved outcomes and fewer complications, helping patients to heal faster and return to daily activities sooner. As technology and techniques continue to advance, the field of interventional radiology is expected to continue to grow and provide even more innovative solutions to a range of medical conditions.

FutureWise Market Research has published a report that provides an insightful analysis of Interventional Radiology Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Interventional Radiology Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Carestream Health
  • Esaote SPA
  • GE Healthcare
  • Hitachi Medical Corporation
  • Hologic Inc.
  • Koninklijke Philips NV
  • Shimadzu Corporation
  • Siemens AG
  • Toshiba Medical Systems Corporation
  • Samsung Medison
  • General Electric Company
  • Canon Medical Systems Corporation
  • Agfa-Gevaert Group
  • Teleflex Incorporated,
  • Cook
  • Analogic Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Trivitron

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Interventional Radiology Market:

  • In May 2021, ESAOTE introduced the MyLab X9 ultrasound device in order to offer the best possible image and data processing quality. It is built on the basis of advanced X ULTRA technology.

  • In March 2021, FUJIFILM Healthcare became a wholly-owned division of FUJIFILM after acquiring Hitachi Ltd.'s diagnostic imaging-related company.

The interventional radiology market has experienced significant growth over the past few years due to several factors, including advancements in technology, the increasing prevalence of chronic illnesses, and the growing demand for minimally invasive procedures. One of the major forces for growth in the interventional radiology market is the increasing prevalence of chronic illnesses such as cancer, cardiovascular disease, and diabetes. These conditions often require frequent imaging and interventional procedures, which has led to a significant increase in demand for interventional radiology services. Technological developments have also played a significant role in driving growth in the interventional radiology market. The development of new imaging modalities such as CT, MRI, and ultrasound has enabled interventional radiologists to perform intricate procedures more precisely and accurately. In addition, the development of new interventional devices and techniques has expanded the range of conditions that can be treated using minimally invasive procedures. For example, the use of endovascular stents has revolutionized the treatment of peripheral artery disease, while the development of radiofrequency ablation has made it possible to treat certain types of cancer without surgery. The growing demand for minimally invasive procedures has also contributed to the growth of the interventional radiology market. Patients are increasingly seeking out procedures that are less invasive and have a lower risk of complications and side effects. The requirement for hospitalisation is decreased, and patients can resume their regular activities more rapidly when minimally invasive operations are carried out on an outpatient basis.

Despite these positive factors, the interventional radiology market also faces several challenges. One of the primary challenges is the high cost of interventional procedures, which can limit access to care for some patients. In addition, there is a shortage of trained interventional radiologists, which could limit the growth potential of the market.

By Product

  • MRI Systems
  • Ultrasound Imaging Systems
  • CT Scanners
  • Angiography Systems
  • Fluoroscopy Systems
  • Biopsy Devices
  • Other Products

By Procedure

  • Angioplasty
  • Angiography
  • Biopsy and Drainage
  • Embolization
  • Thrombolysis
  • Other Procedures

By Application

  • Cardiology
  • Urology And Nephrology
  • Oncology
  • Gastroenterology
  • Other Applications

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. The market in North America is being driven by the rising prevalence of chronic illnesses brought on by changing lifestyles and the growing need for more affordable solutions. Cardiac catheterization is frequently used to identify and treat many types of heart conditions. Annually, the United States performs more than a million cardiac catheterizations and angiographic procedures. Cancer patients may get a variety of radiological treatments. For instance, radiofrequency ablation and microwave ablation can harm cancer cells directly, whereas transarterial chemoembolization can cut off the blood supply to a tumor. Additionally, during the forecasted time period, new product launches and developments are anticipated to fuel the growth of the North American market. For instance, Siemens Healthineers introduced Naeotom Alpha, one of the first photon-counting CT scanners, in November 2021. The system has received approval for clinical usage in the US and EU. Furthermore, the market in North America is being driven by the increased incidence of chronic diseases, including cancer and diabetes, as well as the potential for minimally invasive, tailored therapies employing imaging guidance.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Interventional Radiology Market By Product, By Procedure, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- Product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Interventional Radiology Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Interventional Radiology Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Interventional Radiology Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Interventional Radiology Market,By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. MRI Systems
        2. Ultrasound Imaging Systems
        3. CT Scanners
        4. Angiography Systems
        5. Fluoroscopy Systems
        6. Biopsy Devices
        7. Other Products

  • 8.   Global Interventional Radiology Market,By Procedure Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Angioplasty
        2. Angiography
        3. Biopsy and Drainage
        4. Embolization
        5. Thrombolysis
        6. Other Procedures

  • 9.   Global Interventional Radiology Market,By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cardiology
        2. Urology And Nephrology
        3. Oncology
        4. Gastroenterology
        5. Other Applications

  • 10.   North America Interventional Radiology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Interventional Radiology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Interventional Radiology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Interventional Radiology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Carestream Health
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Esaote SPA
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. GE Healthcare
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Hitachi Medical Corporation
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Hologic Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Koninklijke Philips NV
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Shimadzu Corporation
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Siemens AG
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Toshiba Medical Systems Corporation
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Samsung Medison
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. General Electric Company
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Canon Medical Systems Corporation
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Agfa-Gevaert Group
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Teleflex Incorporated,
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Cook
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Analogic Corporation
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Trivitron
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients